Composition, form of production and packaging
? The chewing tablets are white, round, flat, oblique to the edge, with an imprint in the form of a brand name ("Bayer's" cross) on one side and "TALCID" on the other.
1 tab.
hydrotalcite 500 mg
[PRING] mannitol, corn starch, magnesium stearate, sodium saccharinate, mint flavor, banana flavor.
10 pieces. - blisters (2) - packs of cardboard.
10 pieces. - blisters (5) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2005.
PHARMACHOLOGIC EFFECT
Antacid preparation. It has a crystalline stratified-mesh structure with a low content of aluminum and magnesium. Talcid provides a quick and long-lasting neutralization of hydrochloric acid of gastric juice without excessive alkalization of gastric contents with maintenance of pH at the optimal therapeutic level between 3 and 5 for 75-90 min; has a gastroprotective effect due to prolonged binding of pepsin, hydrochloric acid, bile acids; It also activates its own stomach protection factors.
PHARMACOKINETICS
Due to the laminated-mesh structure of Talcida, the release of aluminum and magnesium ions occurs in the stomach gradually depending on the pH level. 1 g of hydrotalcite has a buffer capacity of 27.8 meq. After taking Talcid, the level of aluminum and magnesium in the blood plasma with normal kidney function remains within the physiological norm, the penetration of aluminum and magnesium ions into the nerve and bone tissues is not observed.
INDICATIONS
- Acute and chronic inflammatory diseases of the mucous membrane of the stomach and duodenum (including gastritis, duodenitis);
- ulcer disease of the stomach and duodenum;
-Disruptions of the function of the gastrointestinal tract associated with improper feeding or intake of drugs that have an irritant effect on the gastric mucosa;
reflux esophagitis;
-burn, belching, feeling of overflow in the stomach.
DOSING MODE
Adults appoint 1-2 tables. 3-4 times / day (1-2 hours after eating and before bedtime). Tablets should be chewed and washed with water. Duration of admission forpeptic ulcer is 4 weeks on average.
A single dose for children is 1 / 2-1 tab.
SIDE EFFECT
Possible: frequent stool (diarrhea).
When taking Talcid, unwanted side effects are rarely observed and are associated mainly with prolonged use of the drug.
CONTRAINDICATIONS
-individual intolerance.
PREGNANCY AND LACTATION
At present, no cases of undesirable effects have been reported with the use of Talcida during pregnancy and lactation (breastfeeding).
In experimental studies, there was no teratogenic effect of Talcida.
APPLICATION FOR FUNCTIONS OF THE LIVER
It is not recommended to apply the drug to patients with impaired renal excretory function.
APPLICATION FOR CHILDREN
A single dose for children is 1 / 2-1 tab.
SPECIAL INSTRUCTIONS
1 tab. Talcida contains 0.0086 XE and a small amount of sodium saccharinate, which makes it possible to prescribe the drug to patients with diabetes mellitus and arterial hypertension.
It is not recommended to apply the drug to patients with impaired renal excretory function.
Do not recommend taking Talcid at the same time with drinks that contain acid (juices, wine).
Talcid should be taken 1-2 hours before or after taking medications containing iron, derivatives of chenodeoxycholic acid, digoxin, cimetidine, coumarin derivatives.
OVERDOSE
At present, no cases of an overdose of Talcid have been reported.
DRUG INTERACTION
With the simultaneous use of Talcid reduces the absorption of tetracycline antibiotics, fluoroquinolones (ciprofloxacin, ofloxacin).
TERMS AND CONDITIONS OF STORAGE
The drug should be stored in a dry, cool place. Shelf life - 5 years.
Conditions of leave from pharmacies
The drug is approved for use as a means of OTC.
